IL165522A0 - Controlled ovarian hyperstimulation - Google Patents

Controlled ovarian hyperstimulation

Info

Publication number
IL165522A0
IL165522A0 IL16552204A IL16552204A IL165522A0 IL 165522 A0 IL165522 A0 IL 165522A0 IL 16552204 A IL16552204 A IL 16552204A IL 16552204 A IL16552204 A IL 16552204A IL 165522 A0 IL165522 A0 IL 165522A0
Authority
IL
Israel
Prior art keywords
ovarian hyperstimulation
controlled ovarian
controlled
hyperstimulation
ovarian
Prior art date
Application number
IL16552204A
Other languages
English (en)
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of IL165522A0 publication Critical patent/IL165522A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16552204A 2002-06-07 2004-12-02 Controlled ovarian hyperstimulation IL165522A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02077221 2002-06-07
PCT/NL2003/000370 WO2003103770A2 (fr) 2002-06-07 2003-06-06 Methode d'hyperstimulation ovarienne controlee et trousse pahrmaceutique a cet usage

Publications (1)

Publication Number Publication Date
IL165522A0 true IL165522A0 (en) 2006-01-15

Family

ID=29724462

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16552204A IL165522A0 (en) 2002-06-07 2004-12-02 Controlled ovarian hyperstimulation

Country Status (21)

Country Link
US (1) US7815912B2 (fr)
EP (1) EP1511537B1 (fr)
JP (1) JP2005530818A (fr)
KR (1) KR20050058285A (fr)
CN (1) CN1684737A (fr)
AU (1) AU2003274929B2 (fr)
BR (1) BR0305033A (fr)
CA (1) CA2488719A1 (fr)
EA (1) EA009371B1 (fr)
ES (1) ES2399962T3 (fr)
IL (1) IL165522A0 (fr)
IS (1) IS7586A (fr)
ME (1) MEP39308A (fr)
MX (1) MXPA04012246A (fr)
NO (1) NO20045304L (fr)
NZ (1) NZ536984A (fr)
PL (1) PL373991A1 (fr)
RS (1) RS105004A (fr)
UA (1) UA81251C2 (fr)
WO (1) WO2003103770A2 (fr)
ZA (1) ZA200409857B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101583363B (zh) * 2007-01-08 2013-08-21 潘塔希生物科学股份有限公司 治疗或预防雌性哺乳动物不育症的方法和此类方法中使用的药物试剂盒
BR112014001274A2 (pt) 2011-07-18 2017-04-18 Arts Biologics As composto de hormônio luteinizante, e, composição farmacêutica
US20150272622A1 (en) 2011-12-22 2015-10-01 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
US9216037B2 (en) 2013-06-21 2015-12-22 Previvo Genetics, Llc Uterine lavage for embryo retrieval
US9282995B2 (en) * 2011-12-22 2016-03-15 Previvo Genetics, Llc Recovery and processing of human embryos formed in vivo
WO2018015497A2 (fr) 2016-07-21 2018-01-25 ObsEva S.A. Régimes posologiques d'antagonistes de l'ocytocine pour favoriser l'implantation d'embryons et prévenir les fausses couches
EP4025207A1 (fr) 2019-09-03 2022-07-13 ObsEva S.A. Régimes posologiques d'antagonistes de l'ocytocine pour favoriser l'implantation d'embryons et prévenir les fausses couches
AU2021218895A1 (en) 2020-02-10 2022-09-15 ObsEva S.A. Biomarkers for oxytocin receptor antagonist therapy
WO2026018221A1 (fr) 2024-07-18 2026-01-22 ReproNovo SA Compositions cristallines pour améliorer l'implantation d'embryons et leurs procédés d'utilisation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0788799A3 (fr) * 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft Antagonistes de LHRH pour le traitement des désordres de la fertilité
CN1199642A (zh) * 1997-05-16 1998-11-25 Asta药物股份公司 治疗不育症的lhrh－拮抗剂
ES2247710T3 (es) 1997-06-20 2006-03-01 Akzo Nobel N.V. Antagonista de gonadotropina.
CZ301912B6 (cs) * 1998-04-23 2010-07-28 Zentaris Ivf Gmbh Lécivo na lécení neplodnosti nitrodeložní inseminací
CN1353617A (zh) * 1999-02-24 2002-06-12 诺沃挪第克公司 不孕症的治疗
US20030092628A1 (en) * 1999-06-23 2003-05-15 De Greef Henrik Johan Matthieu Maria Gonadotropin releasing hormone antagonist
AU6263800A (en) * 1999-06-23 2001-01-31 Akzo Nobel N.V. Gonadotropin releasing hormone antagonist
MEP38808A (en) * 2001-09-12 2011-02-10 Merck Serono Sa Use of lh in controlled ovarian hyperstimulation
ATE376839T1 (de) 2001-12-21 2007-11-15 Pantarhei Bioscience Bv Verfahren zur regulierten hyperstimulation der eierstöcke und pharmazeutisches kit zur verwendung in diesem verfahren

Also Published As

Publication number Publication date
NO20045304L (no) 2005-02-07
BR0305033A (pt) 2004-11-09
ES2399962T3 (es) 2013-04-04
CA2488719A1 (fr) 2003-12-18
EA009371B1 (ru) 2007-12-28
CN1684737A (zh) 2005-10-19
AU2003274929A1 (en) 2003-12-22
US7815912B2 (en) 2010-10-19
MEP39308A (en) 2011-02-10
AU2003274929B2 (en) 2008-04-10
EA200401619A1 (ru) 2005-06-30
WO2003103770A2 (fr) 2003-12-18
US20050235374A1 (en) 2005-10-20
UA81251C2 (en) 2007-12-25
MXPA04012246A (es) 2005-04-08
RS105004A (sr) 2007-02-05
EP1511537A2 (fr) 2005-03-09
PL373991A1 (en) 2005-09-19
NZ536984A (en) 2008-01-31
KR20050058285A (ko) 2005-06-16
EP1511537B1 (fr) 2012-11-21
IS7586A (is) 2004-12-03
WO2003103770A3 (fr) 2004-04-22
ZA200409857B (en) 2006-02-22
JP2005530818A (ja) 2005-10-13

Similar Documents

Publication Publication Date Title
GB2385111B (en) Control apparatus
EP1547230A4 (fr) Systeme de deplacement commande
GB0201228D0 (en) Access control
AP2004003119A0 (en) Substituted hydroxyethylamines
GB0211257D0 (en) Novel heterocycles
DE60314378D1 (en) Kristalline polymorphe form von irinotecan-hyrochlorid
GB0221167D0 (en) Control apparatus
AU2003225846A8 (en) Variable response bushing
GB0208877D0 (en) Behicle control
PL372307A1 (en) Substituted 4-aminocyclohexanols
IL166740A0 (en) Substituted heterocyclylpyrimidines
GB0209989D0 (en) Novel heterocycles
GB2395074B (en) Control circuit
AU150572S (en) Control unit
GB0327641D0 (en) Control arrangement
GB0204681D0 (en) Ink-key control
GB0511237D0 (en) Control unit
PL377325A1 (pl) Podstawione benzodioksepiny
GB2395073B (en) Control circuit
GB0209988D0 (en) Novel Heterocycles
GB0301989D0 (en) Control belt
GB0301420D0 (en) Control belt
CA94851S (en) Lighting control
CA94850S (en) Lighting control
CA94852S (en) Lighting control